Tag: EGFR
Articles
- ER+/PR- breast cancer
- HER2/neu overexpressing breast cancer
- Inflammatory breast cancer
- What should ER+/PR- breast cancer patients and survivors eat?
- What should inflammatory breast cancer patients and survivors eat?
News
- Although similar, ER+/PR- breast cancer is more aggressive than ER+/PR+
- Epidermal growth factor receptor (EGFR) expression associated with worse breast cancer prognosis
- Ki67 proliferation index predicts progression of LCIS to invasive breast cancer
- What are the characteristics of breast cancer with low risk of recurrence?
Foods
Studies
- A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative
- Antiproliferative effects of selective cyclooxygenase-2 inhibitor modulated by nimotuzumab in estrogen-dependent breast cancer cells
- Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
- Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway
- Differential response from neoadjuvant chemotherapy across breast cancer subtypes
- Effects of Intermittent and Chronic Calorie Restriction on Mammalian Target of Rapamycin (mTOR) and IGF-I Signaling Pathways in Mammary Fat Pad Tissues and Mammary Tumors
- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes
- ER+ PR- breast cancer defines a unique subtype of breast cancer that is driven by growth factor signaling and may be more likely to respond to EGFR targeted therapies
- Fucoidan from Laminaria cichorioides inhibits AP-1 transactivation and cell transformation in the mouse epidermal JB6 cells
- Grape polyphenols inhibit Akt-mTOR signaling and breast cancer progression to act as chemosensitization agents for the epidermal growth factor receptor inhibitor gefitinib
- High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients
- Identification of cell cycle and apoptosis related gene expression by curcumin in an in vitro model for ductal carcinoma in situ
- Indole-3-carbinol-induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment
- Influence of Berry-Polyphenols on Receptor Signaling and Cell-Death Pathways: Implications for Breast Cancer Prevention
- Molecular Signaling Distinguishes Early ER Positive Breast Cancer Recurrences Despite Adjuvant Tamoxifen
- Molecular subtyping of male breast cancer by immunohistochemistry
- Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells
- Potential mechanisms whereby the lignan or oil components of flaxseed, alone or in combination with tamoxifen exert their effect on breast cancer
- Predictors of Pathologic Complete Response After Standard Neoadjuvant Chemotherapy in Triple-negative Breast Carcinoma
- Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G2/M arrest and apoptosis
- Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells
- Single-center experience of male breast cancer: Molecular pathology and potential treatment implications
- Surgical Injury Enhances the Expression of Genes That Mediate Breast Cancer Metastasis to the Lung
- Tumour characteristics among women with very low-risk breast cancer